Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 68.30M
March 31, 2026 68.10M
December 31, 2025 67.90M
September 30, 2025 67.90M
June 30, 2025 67.70M
March 31, 2025 67.50M
December 31, 2024 67.30M
September 30, 2024 67.20M
June 30, 2024 67.10M
March 31, 2024 66.80M
December 31, 2023 66.70M
September 30, 2023 66.80M
June 30, 2023 66.80M
March 31, 2023 66.60M
December 31, 2022 66.40M
September 30, 2022 66.00M
June 30, 2022 67.00M
March 31, 2022 41.85M
December 31, 2021 41.69M
September 30, 2021 41.67M
June 30, 2021 41.63M
March 31, 2021 42.54M
December 31, 2020 42.29M
September 30, 2020 42.04M
June 30, 2020 41.95M
Date Value
March 31, 2020 42.00M
December 31, 2019 41.87M
September 30, 2019 41.64M
June 30, 2019 41.42M
March 31, 2019 39.81M
December 31, 2018 39.39M
September 30, 2018 39.00M
June 30, 2018 39.00M
March 31, 2018 37.41M
December 31, 2017 34.54M
September 30, 2017 33.98M
June 30, 2017 33.41M
March 31, 2017 33.19M
December 31, 2016 32.90M
September 30, 2016 32.64M
June 30, 2016 32.39M
March 31, 2016 32.32M
December 31, 2015 33.32M
September 30, 2015 33.42M
June 30, 2015 33.89M
March 31, 2015 34.49M
December 31, 2014 34.43M
September 30, 2014 34.40M
June 30, 2014 34.27M
March 31, 2014 34.22M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 78.87M
Neogen Corp. 217.70M
Aspira Women's Health, Inc. 46.63M
VolitionRX Ltd. 12.04M
Lucid Diagnostics, Inc. 190.76M